Career Updates

Aug 29, 2025, 17:20

Anas Younes Has Been Appointed Chief Medical Officer at AstraZeneca

Anas Younes, Senior VP of Global Head of Hematology (Early and Late Stage), Oncology R&D, Chairman of the Board of Directors of Acerta, and Chief Medical Officer, and Head of Haematology R&D at AstraZeneca, shared a post on LinkedIn:

“I’m honored to be appointed Chief Medical Officer at AstraZeneca.

This role deepens the patient focus that has anchored my career as a clinician-scientist – from caring for patients with lymphoma and leading clinical trials in academia, to advancing the next wave of potential new blood cancer medicines.

As CMO, and Global Head of Haematology R&D, I’m committed to working with purpose and urgency to bring our medicines to patients around the world with the aim to improve health outcomes and equity.”

Anas Younes, M.D., is the Senior Vice President and Global Head of Hematology (Early and Late Stage), Oncology RandD at AstraZeneca, where he leads hematology oncology research and development from early discovery and target identification to first-in-human studies, late-stage trials, and regulatory approvals. He also serves as Chairman of the Board of Directors of Acerta and Chief Medical Officer and Head of Hematology RandD at AstraZeneca.

A clinician-scientist with over 25 years of experience in lymphoma care and research, Dr. Younes previously served as Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center (MSKCC), Special Advisor to the Chief of Medicine for Research, and principal investigator for numerous clinical trials that led to the FDA approval of the first targeted therapy and first immune checkpoint inhibitor for lymphoma, along with multiple new treatment indications for lymphoid malignancies.

Before MSKCC, he spent two decades at the University of Texas MD Anderson Cancer Center, where he directed clinical and translational research in lymphoma and myeloma and led National Cancer Institute-funded Specialized Programs of Research Excellence (SPORE) and Leukemia and Lymphoma Society-funded CAR T-cell therapy programs.

Dr. Younes has extensively published in peer-reviewed journals and served as principal investigator for many national and international clinical trials. He earned his medical degree from Damascus University School of Medicine and completed residencies in pathology and internal medicine, followed by a fellowship in hematology/oncology at MSKCC.

You can find more posts featuring Anas Younes on OncoDaily.

OncoInfluencers to Follow on Social Media: Anas Younes

Anas Younes Has Been Appointed Chief Medical Officer at AstraZeneca